Biogen gets European approval for postpartum depression treatment
Go back to Biogen gets European approval for postpartum depression treatment| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 196.18 +3.56 (1.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $192.62 | 52 Week High | $333.65 | |||
| Open | $195.40 | 52 Week Low | $223.02 | |||
| Day High | $196.23 | P/E | 25.12 | |||
| Day Low | $193.45 | EPS | $7.81 | |||
| Volume | 72,880 | |||||
| SUPERNUS PHARM (NASDAQ: SUPN) | Delayed: 45.30 +0.82 (1.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.48 | 52 Week High | $26.84 | |||
| Open | $44.86 | 52 Week Low | $9.51 | |||
| Day High | $45.69 | P/E | N/A | |||
| Day Low | $44.70 | EPS | $-2.62 | |||
| Volume | 37,000 | |||||
